VilosLab
Recent Publications
Uptate of nanoparticles in microglial cells.
Publications
Gonzalez, A., Simon, F., Achiardi, O., Vilos, C., Cabrera, D., and Cabello-Verrugio, C. The Critical Role of Oxidative Stress in Sarcopenic Obesity. Oxidative Medicine and Cellular Longevity 2021, 4493817.
Mauricio Cabaña-Brunod, Pablo A. Herrera, Valeria Márquez-Miranda, Felipe M. Llancalahuen, Yorley Duarte, Danilo González-Nilo, Juan A. Fuentes, Cristian Vilos, Luis Velásquez & Carolina Otero (2021) Development of a PHBV nanoparticle as a peptide vehicle for NOD1 activation, Drug Delivery, 28:1, 1020-1030.
Cisterna, B.A., Vargas, A.A., Puebla, C., Fernández, P., Escamilla, R., Lagos, C.F., Matus, M.F., Vilos, C., Cea, L.A., Barnafi, E., Gaete, H., Escobar, D.F., Cardozo, C.P., Sáez, J.C. Active acetylcholine receptors prevent the atrophy of skeletal muscles and favor reinnervation. 2020. Nature Communications 11(1),1073.
García-López, J.P., Vilos, C., Feijóo, C.G. Zebrafish, a model to develop nanotherapeutics that control neutrophils response during inflammation. 2019. Journal of Controlled Release. 313, pp. 14-23
Abrigo, J., T. Marin, F. Aguirre, F. Tacchi, C. Vilos, F. Simon, M. Arrese, D. Cabrera and C. Cabello-Verrugio. N-Acetyl Cysteine attenuates the sarcopenia and muscle apoptosis induced by chronic liver disease. Curr Mol Med. 2019 Sep 17.
Abrigo, J., F. Simon, D. Cabrera, C. Vilos and C. Cabello-Verrugio (2019). Mitochondrial Dysfunction in Skeletal Muscle Pathologies. 2019. Curr Protein Pept Sci 20(6): 536-546.
Cabello-Verrugio, C., C. Vilos, R. Rodrigues-Diez and L. Estrada (2018). Oxidative Stress in Disease and Aging: Mechanisms and Therapies. 2018. Oxid Med Cell Longev 2018: 2835189.
Eduardo Fuentes, Basit Yameen, Soung- Jae Bong, Carolina Salvador-Morales, Ivan Palomo, Cristian Vilos. Antiplatelet effect of differentially charged PEGylated lipid-polymer nanoparticles. Nanomedicine: Nanotechnology, Biology and Medicine. 2017 Apr;13(3):1089-1094.
Bruno A. Cisterna, Nazila Kamaly, Won Il Choi, Ali Tavakkoli, Omid C. Farokhzad, Cristian Vilos. Targeted nanoparticles for colorectal cancer. Nanomedicine (Lond). 2016 ,Vol. 11, No. 18, Pages 2443-2456.
B. Yameen, C. Vilos, W.I. Choi, A. Whyte, J. Huang, L. Pollit, O.C. Farokhzad. Drug delivery nanocarriers from fully degradable PEG-conjugated polyester with reduction-responsive backbone. Chem. Eur. J. 2015, 21,1–6.
Paula Solar, Guillermo González, Cristian Vilos, Natalia Herrera, Natalia Juica, Mabel Moreno, Felipe Simon and Luis Velásquez. Multifunctional polymeric nanoparticles doubly loaded with SPION and ceftiofur retain their physical and biological properties. Journal of Nanobiotechnology (2015) 13:14.
Choi, Won; Kamaly, Nazila; Riol-Blanco, Lorena; Lee, In-Hyun; Wu, Jun; Swami, Archana; Vilos, Cristian; Yameen, Basit; Yu, Mikyung; Shi, Jinjun; Tabas, Ira; von Andrian, Ulrich; Jon, Sangyong; Farokhzad, Omid C. A Solvent-free Thermosponge Nanoparticle Platform for Efficient Delivery of Labile Proteins. Nano Letters. Nan.o Lett. 2014 Nov 12;14(11):6449-55.
Patent Applications
– Constandil L., Ibarra P., Vilos C., Veláquez L., Pelissier T., Laurido C., Hernández A. Nanoparticles With Biodegradable and Biocompatible Polymer PLGA, Loaded With the Drug for Human Use Pentoxifylline. Publication number: WO2014075203 A8 – PCT number: PCT/CL2013/000084 – Also published as: WO2014075203A8.
– Shi J., Zeyu X., Votruba A., Vilos C., Farokhzad O. Lipid-polymer hybrid particles. Publication number: US20130315831 A1 – Application number: US 13/820,351 – PCT number: PCT/US2011/050334 – Also published as: WO2012031205A2, WO2012031205A3.
– Vilos C. Velásquez L. A., Orihuela P., Rios M. Injectable veterinary composition for sustained release of ceftiofur and florfenicol in animal species, which comprises poly(lacticcoglycolic acid) (plga) microparticles, and the method for the preparation thereof. Publication number: WO2013071456 A3 – Application number: PCT/CL2012/000066 – Also published as: WO2013071456A2.
– Vilos C., Velásquez LA., Constandil L., Rios M. Injectable veterinary composition for controlled, sustained release of ceftiofur and florfenicol in animal species, based on polyhydroxybutyrate hydroxyvalerate (phbv) microparticles. Publication number: WO2013071457 A1 – Application number: PCT/CL2012/000067 – Also published as WO2013071457A4.